论文部分内容阅读
27例急性非淋巴细胞白血病(ANLL)患者(男14例,女13例,中数年龄45岁)中10例M_2,7例M_3,5例M_4、M_0、M_1、M_5、M_6及未分类各1例。诊断时中数血红蛋白值86g/L,中数白细胞数8.5×10~9/L,外周血及骨髓涂片中原始细胞中数百分率分别为63％、48.6％,中数血小板数57.5×10~9/L。患者均接受联合化疗。外周血细胞数正常、骨髓中细胞数正常。原始细胞<5％为完全缓解(CR),其他患者视为治疗反应差(PR)。组织多肽抗原(TPA)血清浓度用双—抗体放射免疫法重复测定,抗原用~(125)I标记。对照组为明显健康的个体。
Among 27 patients with acute non-lymphocytic leukemia (ANLL), there were 10 M_2, 7 M_3, 5 M_4, M_0, M_1, M_5, M_6, M_6 and M_6 subgroups in 14 males and 13 females with a median age of 45 years 1 case. The median hemoglobin value at diagnosis was 86 g / L, the median number of white blood cells was 8.5 × 10 ~ 9 / L, and the percentage of blasts in peripheral blood and bone marrow smears were 63% and 48.6%, respectively. The median platelet count was 57.5 × 10 ~ 9 / L. Patients received combination chemotherapy. Normal peripheral blood cells, normal bone marrow cells. Primary cells <5% of complete remission (CR), the other patients treated with poor response (PR). Tissue peptide antigen (TPA) serum concentrations were measured by dual-antibody radioimmunoassay repeated antigen with ~ (125) I labeled. Control subjects were apparently healthy individuals.